009300.KS · 삼아제약
South Korea · RS rating 68 · As of 2026-10-14
| Price | 13,970.00 KRW |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 63 / 70 / 45 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 22 / 48 |
| Industry group (rank) | Finance-Invest Bnk/Bkrs (41) |
| EPS growth Q/Q | +95.3% |
| Sales growth Q/Q | +6.5% |
| Distance from 52-week high | +18.2% |
| Market cap (USD) | $63.6M |